NCT03448393 2025-06-04
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × Antiemetics × Other hematologic neoplasm × Clear all